Pregnancy in the Cardiac Catheterization Laboratory: A Safe and Feasible Endeavor.


Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
04 2021
Historique:
entrez: 20 4 2021
pubmed: 21 4 2021
medline: 16 10 2021
Statut: ppublish

Résumé

Concerns over radiation exposure are ubiquitous to all interventional cardiologists; however, fear of exposure during childbearing years disproportionately deters women from entering the field. This review summarizes the available data on occupational radiation exposure during pregnancy with an emphasis on radiation quantification, the impact of exposure at various stages of fetal development, societal recommendations for safe levels of exposure during gestation, threshold levels necessary to induce fetal harm, and safe practices for the pregnant interventionalist. Reconciling the available information, we conclude that pregnancy in the cardiac catheterization laboratory is both safe and feasible. This review also highlights new technologies that may augment standard radiation safety techniques and are of particular interest to the pregnant interventional cardiologist. Finally, we propose steps to improve female representation in this field, underscoring the importance of a sex-balanced workforce.

Identifiants

pubmed: 33877865
doi: 10.1161/CIRCINTERVENTIONS.120.009636
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e009636

Auteurs

Amy E Cheney (AE)

Department of Internal Medicine, Division of Cardiology, University of Washington, Seattle.

Logan L Vincent (LL)

Department of Internal Medicine, Division of Cardiology, University of Washington, Seattle.

James M McCabe (JM)

Department of Internal Medicine, Division of Cardiology, University of Washington, Seattle.

Kathleen E Kearney (KE)

Department of Internal Medicine, Division of Cardiology, University of Washington, Seattle.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH